首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1457994

全球心臟病学和神经病学 IVD 市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global IVD In Cardiology And Neurology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球心臟病学和神经病学市场 IVD 需求预计将从 2023 年的 168.8 亿美元达到近 395.7 亿美元的市场规模，2024 年至 2032 年的研究期间CAGR为 9.93%。

心臟病学和神经病学中的体外诊断 (IVD) 是指对体外样本进行诊断测试，以评估心臟和神经系统状况。这些测试包括生物标记测量、遗传分析和影像研究，有助于心血管和神经系统疾病的早期检测、监测和治疗计划。

市场动态

心臟病学和神经病学领域的 IVD（体外诊断）市场受到全球心血管和神经系统疾病盛行率上升的推动。 IVD 设备的技术进步（例如生物标记发现和分子诊断）提高了诊断精度。医疗保健支出的增加、人口老化的加剧以及预防性医疗保健的积极倡议进一步刺激了市场扩张。此外，将人工智慧和资料分析整合到 IVD 设备中有助于个人化和高效的患者诊断。然而，市场限制包括与监管复杂性和新型诊断技术严格审批流程相关的挑战。克服这些限制需要简化监管途径，并持续努力，使心臟病学和神经病学市场的医疗保健提供者更容易获得先进的 IVD 技术，并更具成本效益。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球心臟病学和神经病学体外诊断市场的各个细分市场进行了包容性评估。体外诊断在心臟病学和神经病学行业的成长和趋势为这项研究提供了整体方法。

市场区隔

心臟病学和神经病学市场报告中的 ivd 的这一部分提供了有关国家和地区级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

依产品类型

仪器
试剂及耗材
软体与服务

依技术

免疫测定
分子诊断
血液学
其他的

按最终用途

医院
临床实验室
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心臟病学和神经病学 IVD 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

全球心臟病学和神经病学 IVD 市场份额（按地区）（代表性图）
全球心臟病学和神经病学 IVD 市场份额

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心臟病学和神经病学IVD 市场的主要参与者包括Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd.、Sysmex Corp.、Siemens Healthineers AG、Quest Diagnostics Inc.、Abbott, BD、Bio-Rad Laboratories, Inc. ., Beckman Coulter, Inc.本部分包含竞争格局的整体视图，其中包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概览、协作、新产品开发、新产品发布以及其他事态发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：心臟病学和神经病学公司 IVD 的竞争格局

Ivd 参与心臟病学和神经病学市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Thermo Fisher Scientific Inc.

公司简介
公司收入
产品
最近的发展

F. Hoffmann-La Roche Ltd.

公司简介
公司收入
产品
最近的发展

Sysmex Corp.

公司简介
公司收入
产品
最近的发展

Siemens Healthineers AG

公司简介
公司收入
产品
最近的发展

Quest Diagnostics Inc.

公司简介
公司收入
产品
最近的发展

Abbott BD

公司简介
公司收入
产品
最近的发展

Bio-Rad Laboratories Inc.

公司简介
公司收入
产品
最近的发展

Beckman Coulter Inc.

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112113943

The global demand for IVD In Cardiology And Neurology Market is presumed to reach the market size of nearly USD 39.57 Billion by 2032 from USD 16.88 Billion in 2023 with a CAGR of 9.93% under the study period 2024 - 2032.

In vitro diagnostics (IVD) in cardiology and neurology refers to diagnostic tests conducted on samples outside the body to assess heart and neurological conditions. These tests include biomarker measurements, genetic analyses, and imaging studies, aiding in the early detection, monitoring, and treatment planning of cardiovascular and neurological diseases.

MARKET DYNAMICS

The IVD (In Vitro Diagnostics) market in cardiology and neurology is driven by the rising prevalence of cardiovascular and neurological disorders globally. Technological advancements in IVD devices, such as biomarker discovery and molecular diagnostics, enhance diagnostic precision. Increased healthcare expenditures, a growing aging population, and proactive initiatives for preventive healthcare further stimulate market expansion. Additionally, integrating artificial intelligence and data analytics into IVD devices aids in personalized and efficient patient diagnostics. However, market restraints encompass challenges related to regulatory complexities and stringent approval processes for novel diagnostic technologies. Overcoming these restraints requires streamlined regulatory pathways and continued efforts to make advanced IVD technologies more accessible and cost-effective for healthcare providers in the cardiology and neurology market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of ivd in cardiology and neurology. The growth and trends of ivd in cardiology and neurology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the ivd in cardiology and neurology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Instruments
Reagents & Consumables
Software And Services

By Technology

Immunoassays
Molecular Diagnostics
Hematology
Others

By End-Use

Hospitals
Clinical Laboratories
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the IVD In Cardiology And Neurology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global IVD In Cardiology And Neurology Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the IVD In Cardiology And Neurology market include Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Sysmex Corp., Siemens Healthineers AG, Quest Diagnostics Inc., Abbott, BD, Bio-Rad Laboratories, Inc., Beckman Coulter, Inc.This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . IVD IN CARDIOLOGY AND NEUROLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Instruments Historic and Forecast Sales by Regions
5.5 Reagents & Consumables Historic and Forecast Sales by Regions
5.6 Software And Services Historic and Forecast Sales by Regions

6 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1 Overview by Technology
6.2 Historical and Forecast Data
6.3 Analysis by Technology
6.4 Immunoassays Historic and Forecast Sales by Regions
6.5 Molecular Diagnostics Historic and Forecast Sales by Regions
6.6 Hematology Historic and Forecast Sales by Regions
6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Clinical Laboratories Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL IVD IN CARDIOLOGY AND NEUROLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IVD IN CARDIOLOGY AND NEUROLOGY COMPANIES

9.1. Ivd In Cardiology And Neurology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF IVD IN CARDIOLOGY AND NEUROLOGY INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Thermo Fisher Scientific Inc.
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. F. Hoffmann-La Roche Ltd.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Sysmex Corp.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Siemens Healthineers AG
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Quest Diagnostics Inc.
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Abbott BD
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Bio-Rad Laboratories Inc.
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Beckman Coulter Inc.
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments